Christopher Dinsmore's Net Worth
$844 Thousand
Who is Christopher Dinsmore?
Christopher Dinsmore does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Kronos Bio, Inc., and Third Harmonic Bio, Inc..
SEC CIK
Christopher Dinsmore's CIK is 0001826766
Past Insider Trading and Trends
2020 was Christopher Dinsmore's most active year for acquiring shares with 3 total transactions. Christopher Dinsmore's most active month to acquire stocks was the month of January. 2021 was Christopher Dinsmore's most active year for disposing of shares, totalling 8 transactions. Christopher Dinsmore's most active month to dispose stocks was the month of November. 2020 saw Christopher Dinsmore paying a total of $99,750.00 for 233,025 shares, this is the most they've acquired in one year. In 2021 Christopher Dinsmore cashed out on 66,520 shares for a total of $722,505.63, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Kronos Bio, Inc. (KRON) Snapshot price: $0.9601
Chief Scientific Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -2.75% | -7.37K |
$1.18 | -$8,718.40 | 260.97K |
Jan 4
| |||
Form 4
| -3.60% | -10.03K |
$1.31 | -$13,091.76 | 268.33K |
Dec 12
| |||
Form 4
| -2.33% | -6.63K |
$1.75 | -$11,624.76 | 278.37K |
Jul 6
| |||
Form 4
| -2.16% | -6.29K |
$1.74 | -$10,918.03 | 285K |
Feb 24
| |||
Form 4
| +69.94% | 119.88K |
—
|
—
| 291.29K |
Feb 15
| |||
Form 4
| -5.31% | -9.14K |
$1.81 | -$16,495.92 | 162.94K |
Dec 12
| |||
Form 4
| +33.88% | 43.55K |
—
|
—
| 172.07K |
Jul 25
| |||
Form 4
| +51.25% | 43.55K |
—
|
—
| 128.52K |
Feb 15
| |||
Form 4
| -11.82% | -11.39K |
$12.37 | -$140,844.69 | 84.97K |
Dec 13
| |||
Form 4
|
—
|
0
|
$12.04 | -$161,146.57 | 96.36K |
Scheduled
|
Oct 4
| ||
Form 4
|
—
|
0
|
$12.59 | -$171,253.56 | 96.36K |
Scheduled
|
Sep 7
| ||
Form 4
|
—
|
0
|
$11.93 | -$159,116.72 | 96.36K |
Scheduled
|
Aug 2
| ||
Form 4
| +1,735.43% | 91.11K |
—
|
—
| 96.36K |
Dec 9
| |||
Form 4
|
∞
| 5.25K |
$19.00 | $99,750.00 | 5.25K |
Oct 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Third Harmonic Bio, Inc. (THRD) Snapshot price: $12
Chief Scientific Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
May 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||